- General Disclosures
- Economic
- Environmental
- Social
| GRI Standard | Disclosure | References | |
|---|---|---|---|
| GRI 2 General Disclosures 2021 |
1. The organization and its reporting practices | ||
| 2-1 | Organizational details | Company Information | |
| 2-2 | Entities included in the organization’s sustainability reporting | Integrated Report 2025PDF | |
| 2-3 | Reporting period, frequency and contact point | Integrated Report 2025PDF | |
| 2-4 | Restatements of information | ー | |
| 2-5 | External assurance | ー | |
| 2. Activities and workers | |||
| 2-6 | Activities, value chain and other business relationships | Annual Securities Report (Japanese only)PDF | |
| 2-7 | Employees | ||
| 2-8 | Workers who are not employees | ー | |
| 3. Governance | |||
| 2-9 | Governance structure and composition | ||
| 2-10 | Nomination and selection of the highest governance body | ||
| 2-11 | Chair of the highest governance body | ||
| 2-12 | Role of the highest governance body in overseeing the management of impacts | ||
| 2-13 | Delegation of responsibility for managing impacts | ||
| 2-14 | Role of the highest governance body in sustainability reporting | How We View Sustainability | |
| 2-15 | Conflicts of interest | ||
| 2-16 | Communication of critical concerns | ||
| 2-17 | Collective knowledge of the highest governance body | ||
| 2-18 | Evaluation of the performance of the highest governance body | ||
| 2-19 | Remuneration policies | ||
| 2-20 | Process to determine remuneration | ||
| 2-21 | Annual total compensation ratio | ー | |
| 4. Strategy, policies and practices | |||
| 2-22 | Statement on sustainable development strategy | Message from the Chairman | |
| 2-23 | Policy commitments | ||
| 2-24 | Embedding policy commitments | ||
| 2-25 | Processes to remediate negative impacts | ||
| 2-26 | Mechanisms for seeking advice and raising concerns | ||
| 2-27 | Compliance with laws and regulations | ESG Data | |
| 2-28 | Membership associations | The Federation of Pharmaceutical Manufacturers' Associations of JAPAN, Japan Pharmaceutical Manufacturers Association, Japan Business Federation, Kansai Pharmaceutical Industries Association | |
| 5. Stakeholder engagement | |||
| 2-29 | Approach to stakeholder engagement | ||
| 2-30 | Collective bargaining agreements | ||
| GRI 3 Material Topics 2021 |
3-1 | Process to determin material topics | Nippon Shinyaku Group’s Issues of Materiality |
| 3-2 | List of material topics | Nippon Shinyaku Group’s Issues of Materiality | |
| 3-3 | Management of material topics | How We View Sustainability | |
| GRI Standard | Disclosure | References | |
|---|---|---|---|
| 201 Economic Performance (2016) |
201-1 | Direct economic value generated and distributed | Business/Financial Information Annual Securities Report (Japanese only)PDF |
| 201-2 | Financial implications and other risks and opportunities due to climate change | － | |
| 201-3 | Defined benefit plan obligations and other retirement plans | Annual Securities Report (Japanese only)PDF | |
| 201-4 | Financial assistance received from government | － | |
| 202 Market Presence (2016) |
202-1 | Ratios of standard entry level wage by gender compared to local minimum wage | － |
| 202-2 | Proportion of senior management hired from the local community | － | |
| 203 Indirect Economic Impacts (2016) |
203-1 | Infrastructure investments and services supported | Global Business Development |
| 203-2 | Significant indirect economic impacts | － | |
| 204 Procurement Practices (2016) |
204-1 | Proportion of spending on local suppliers | － |
| 205 Anti-corruption (2016) |
205-1 | Operations assessed for risks related to corruption | Governance (Compliance/Risk Management) |
| 205-2 | Communication and training about anti-corruption policies and procedures | Governance (Compliance/Risk Management)ESG Data | |
| 205-3 | Confirmed incidents of corruption and actions taken | － | |
| 206 Anti-competitive Behavior (2016) |
206-1 | Legal actions for anti-competitive behavior, anti-trust, and monopoly practices | － |
| 207 Tax (2019) |
207-1 | Approach to tax | － |
| 207-2 | Tax governance, control, and risk management | － | |
| 207-3 | Stakeholder engagement and management of concerns related to tax | － | |
| 207-4 | Country-by-country reporting | － | |
| GRI Standard | Disclosure | References | |
|---|---|---|---|
| 301 Materials (2016) |
301-1 | Materials used by weight or volume | ESG Data |
| 301-2 | Recycled input materials used | － | |
| 301-3 | Reclaimed products and their packaging materials | ESG Data | |
| 302 Energy (2016) |
302-1 | Energy consumption within the organization | The Environment (Response to Climate Change)ESG Data |
| 302-2 | Energy consumption outside of the organization | － | |
| 302-3 | Energy intensity | － | |
| 302-4 | Reduction of energy consumption | ESG Data | |
| 302-5 | Reductions in energy requirements of products and services | － | |
| 303 Water (2018) |
303-1 | Interactions with water as a shared resource | The Environment (Promoting the Recycling of Resources)ESG Data |
| 303-2 | Management of water discharge-related impacts | － | |
| 303-3 | Water withdrawal | The Environment (Promoting the Recycling of Resources)ESG Data | |
| 303-4 | Water discharge | ESG Data | |
| 303-5 | Water consumption | The Environment (Promoting the Recycling of Resources)ESG Data | |
| 304 Biodiversity (2016) |
304-1 | Operational sites owned, leased, managed in, or adjacent to, protected areas and areas of high biodiversity value outside protected areas | － |
| 304-2 | Significant impacts of activities, products, and services on biodiversity | － | |
| 304-3 | Habitats protected or restored | The Environment (Conservation of Biodiversity) | |
| 304-4 | IUCN Red List species and national conservation list species with habitats in areas affected by operations | － | |
| 305 Emissions (2016) |
305-1 | Direct (Scope 1) GHG emissions | The Environment (Response to Climate Change)ESG Data |
| 305-2 | Energy indirect (Scope 2) GHG emissions | The Environment (Response to Climate Change)ESG Data | |
| 305-3 | Other indirect (Scope 3) GHG emissions | － | |
| 305-4 | GHG emissions intensity | － | |
| 305-5 | Reduction of GHG emissions | ESG Data | |
| 305-6 | Emissions of ozone-depleting substances (ODS) | － | |
| 305-7 | Nitrogen oxides (NOX), sulfur oxides (SOX), and other significant air emissions | ESG Data | |
| 306 Waste (2020) |
306-1 | Waste generation and significant waste-related impacts | The Environment (Promoting the Recycling of Resources) |
| 306-2 | Management of significant waste-related impacts | The Environment (Promoting the Recycling of Resources) | |
| 306-3 | Waste generated | The Environment (Promoting the Recycling of Resources)ESG Data | |
| 306-4 | Waste diverted from disposal | The Environment (Promoting the Recycling of Resources)ESG Data | |
| 306-5 | Waste directed to disposal | The Environment (Promoting the Recycling of Resources)ESG Data | |
| 307 Environmental Compliance (2016) |
307-1 | Non-compliance with environmental laws and regulations | ESG Data |
| 308 Supplier Environmental Assessment (2016) |
308-1 | New suppliers that were screened using environmental criteria | Society (Supply Chain Management) |
| 308-2 | Negative environmental impacts in the supply chain and actions taken | Society (Supply Chain Management) | |
| GRI Standard | Disclosure | References | |
|---|---|---|---|
| 401 Employment (2016) |
401-1 | New employee hires and employee turnover | ESG Data |
| 401-2 | Benefits provided to full-time employees that are not provided to temporary or part-time employees | － | |
| 401-3 | Parental leave | Human Capital (Labor Practices) | |
| 402 Labor/Management Relations (2016) |
402-1 | Minimum notice periods regarding operational changes | － |
| 403 Occupational Health and Safety (2018) |
403-1 | Occupational health and safety management system | Human Capital (Safety and Health) |
| 403-2 | Hazard identification, risk assessment, and incident investigation | Human Capital (Safety and Health) | |
| 403-3 | Occupational health services | Human Capital (Safety and Health) | |
| 403-4 | Worker participation, consultation, and communication on occupational health and safety | － | |
| 403-5 | Worker training on occupational health and safety | － | |
| 403-6 | Promotion of worker health | Human Capital (Well-being Management) | |
| 403-7 | Prevention and mitigation of occupational health and safety impacts directly linked by business relationships | Human Capital (Safety and Health) | |
| 403-8 | Workers covered by an occupational health and safety management system | Human Capital (Safety and Health) | |
| 403-9 | Work-related injuries | Human Capital (Safety and Health) | |
| 403-10 | Work-related ill health | － | |
| 404 Training and Education (2016) |
404-1 | Average hours of training per year per employee | Human Capital (Human Resources)ESG Data |
| 404-2 | Programs for upgrading employee skills and transition assistance programs | Human Capital (Human Resources) | |
| 404-3 | Percentage of employees receiving regular performance and career development reviews | － | |
| 405 Diversity and Equal Opportunity (2016) |
405-1 | Diversity of governance bodies and employees | Human Capital (DE&I)ESG Data |
| 405-2 | Ratio of basic salary and remuneration of women to men | － | |
| 406 Non-discrimination (2016) |
406-1 | Incidents of discrimination and corrective actions taken | － |
| 407 Freedom of Association and Collective Bargaining (2016) |
407-1 | Operations and suppliers in which the right to freedom of association and collective bargaining may be at risk | － |
| 408 Child Labor (2016) |
408-1 | Operations and suppliers at significant risk for incidents of child labor | － |
| 409 Forced or Compulsory Labor (2016) |
409-1 | Operations and suppliers at significant risk for incidents of forced or compulsory labor | － |
| 410 Security Practices (2016) |
410-1 | Security personnel trained in human rights policies or procedures | － |
| 411 Rights of Indigenous Peoples (2016) |
411-1 | Incidents of violations involving rights of indigenous peoples | － |
| 412 Human Rights Assessment (2016) |
412-1 | Operations that have been subject to human rights reviews or impact assessments | － |
| 412-2 | Employee training on human rights policies or procedures | － | |
| 412-3 | Significant investment agreements and contracts that include human rights clauses or that underwent human rights screening | － | |
| 413 Local Communities (2016) |
413-1 | Operations with local community engagement, impact assessments, and development programs | Society (Contribution to children and local communities) Integrated Report2025 (Contributing to People’s Health through the Creation of Products and Services with Unique Characteristics)PDF Integrated Report2025(Business Activities : Functional Food)PDF |
| 413-2 | Operations with significant actual and potential negative impacts on local communities | － | |
| 414 Supplier Social Assessment (2016) |
414-1 | New suppliers that were screened using social criteria | Society（Supply Chain Management) |
| 414-2 | Negative social impacts in the supply chain and actions taken | Society（Supply Chain Management) | |
| 415 Public Policy (2016) |
415-1 | Political contributions | － |
| 416 Customer Health and Safety (2016) |
416-1 | Assessment of the health and safety impacts of product and service categories | Pharmaceuticals Division (Research & Development) Pharmaceuticals Division (Production) Integrated Report2025 (Business Activities : Pharmaceuticals/R&D)PDF Integrated Report2025 (Business Activities : Resource Procurement, Production & Assurance)PDF |
| 416-2 | Incidents of non-compliance concerning the health and safety impacts of products and services | － | |
| 417 Marketing and Labeling (2016) |
417-1 | Requirements for product and service information and labeling | Pharmaceuticals Division (Production) Integrated Report2025 (Business Activities : Resource Procurement, Production & Assurance)PDF |
| 417-2 | Incidents of non-compliance concerning product and service information and labeling | Pharmaceuticals Division (Production) Integrated Report2025 (Business Activities : Resource Procurement, Production & Assurance)PDF | |
| 417-3 | Incidents of non-compliance concerning marketing communications | Pharmaceuticals Division (Sales) Integrated Report2025 (Business Activities : Sales)PDF | |
| 418 Customer Privacy (2016) |
418-1 | Substantiated complaints concerning breaches of customer privacy and losses of customer data | － |
| 419 Socioeconomic Compliance (2016) |
419-1 | Non-compliance with laws and regulations in the social and economic area | － |